[1] CHEN W Q,ZHENG R S,BAADE P D,et al.Cancer statistics in China,2015[J].CA Canc J Clin,2016,66(2):117-120.
[2] VECCHIA C L.Ovarian cancer[J].Eur J Cancer Prev,2017,26(1):55-62.
[3] GATE M A,ROSNER B A,HECHT J L,et al.Risk factors for epithelial ovarian cancer by histologic subtype[J].Am J Epidemiol,2009,171(1):45-53.
[4] WANG C P,LIANG Z Z,LIU X,et al.The association between endometriosis,tubal ligation,hysterectomy and epithelial ovarian cancer:meta-analyses[J].Int J Environ Res Public Health,2016,13(11):1138.
[5] SHIH L M,KURMAN R.Ovarian tumorigenesis:a proposed model based on morphological and molecular genetic analysis[J].Am J Pathol,2004,164(5):1511-1518.
[6] SHAHANAVAJ K,GIL-BAZO I,CASTIGLIA M,et al.Cancer and the microbiome:potential applications as new tumor biomarker[J].Expert Rev Anticancer Ther,2015,15(3):317-330.
[7] BOVOLENTA P,ESTEVE P,RUIZ J M,et al.Beyond Wnt inhibition:new functions of secreted Frizzled-related proteins in development and disease[J].J Cell Sci,2008,121(Pt 6):737-746.
[8] MERT I,WALTHER-ANTONIO M,MARIANI A.Case for a role of the microbiome in gynecologic cancers:Clinician's perspective[J].J Obstet Gynaecol Res,2018,44(9):1693-1704.
[9] HARO C,MONTES-BORREGO M,TINAHONES F J,et al.Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population[J].J Clin Endocrinol Metab,2016,101(1):233-242.
[10] MINTER M R,ZHANG C,LEONE V,et al.Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease[J].Sci Rep,2016,6(1):30028.
[11] KUPER H,ADAMI H O,TRICHOPOULOS D.Infections as a major preventable cause of human cancer[J].J Intern Med,2000,248(3):171-183.
[12] AGITO M D,ATREJA A,RIZK M K.Fecal microbiota transplantation for recurrent C difficile infection:Ready for prime time?[J].Cleve Clin J Med,2013,80(2):101-108.
[13] RAFA?K,TOI裇KA A,MAZUREK A,et al.Inflammation and ovarian cancer--current views[J].Ginekol Pol,2013,84(4):293-297.
[14] SHANMUGHAPRIYA S,SENTHILKUMAR G,VINODHINI K,et al.Viral and bacterial aetiologies of epithelial ovarian cancer[J].Eur J Clin Microbiol Infect Dis,2012,31(9):2311-2317.
[15] ZHOU B,SUN C Y,HUANG J,et al.The biodiversity composition of microbiome in ovarian carcinoma patients[J].Sci Rep,2019,9(1):1691.
[16] HANDLER M Z,HANDLER N S,MAJEWSKI S,et al.Human papillomavirus vaccine trials and tribulations[J].J Am Acad Dermatol,2015,73(5):743-756.
[17] MUÑOZ N,BOSCH F X,DE SANJOSÉ S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348(6):518-527.
[18] COBOS C,FIGUEROA J A,MIRANDOLA L,et al.The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy:a review[J].Int Rev Immunol,2014,33(5):383-401.
[19] ROSA M I,SLIVA G D,SOUZA M V,et al.The prevalence of human papillomavirus in ovarian cancer:a systematic review[J].Int Rev Immunol,2013,23(3):437-441.
[20] ROOS P,ORLANDO P A,FAGERSTROM R M,et al.In North America,some ovarian cancers express the oncogenes of preventable human papillomavirus HPV-18[J].Sci Rep,2015,5(1):8645.
[21] ZHANG P P,ZHOU L,CAO J S,et al.Possible epithelial ovarian cancer association with HPV18 or HPV33 infection[J].Asian Pac J Cancer Prev,2016,17(6):2959-2964.
[22] MAHMOOD F M,KADHIM H S,MOUSA A L,et al.Detection of human papillomavirus-16 e6-oncoprotein in epithelial ovarian tumors samples of iraqi patients[J].Jundishapur J Microbiol,2014,7(9):11945.
[23] FARZANEH F,NADJI S A,KHOSRAVI D,et al.Lack of HPV in benign and malignant epithelial ovarian tumors in Iran[J].Asian Pac J Cancer Prev,2017,18(5):1233-1236.
[24] MVNGER K,BALDWIN A,EDWARDS K M,et al.Mechanisms of human papillomavirus-induced oncogenesis[J].J Virol,2004,78(21):11451-11460.
[25] GREGOIRE L,RABAH R,SCHMELZ E M,et al.Spontaneous malignant transformation of human ovarian surface epithelial cells in vitro[J].Clin Cancer Res,2001,7(12):4280-4287.
[26] KEITA M,WANG Z Q,PELLETIER J F,et al.Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression[J].Gynecol Oncol,2013,128(2):356-363.
[27] SAMUDIO-RUIZ S L,HUDSON L G.Increased DNA methyltransferase activity and DNA methylation following epidermal growth factor stimulation in ovarian cancer cells[J].Epigenetics,2014,7(3):216-224.
[28] MONTAVON C,GLOSS B S,WARTON K,et al.Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer[J].Gynecol Oncol,2012,124(3):582-588.
[29] AL-SHABANAH O A,HAFEZ M M,HASSAN Z K,et al.Methylation of SFRPs and APC genes in ovarian cancer infected with high risk human papillomavirus[J].Asian Pac J Cancer Prev,2014,15(6):2719-2725.
[30] HASSAN Z K,HAFEZ M M,KAMEL M M,et al.Human papillomavirus genotypes and methylation of CADM1,PAX1,MAL and ADCYAP1 genes in epithelial ovarian cancer patients[J].Asian Pac J Cancer Prev,2017,18(1):169-176.
[31] MITCHELL C,PRABHU M.Pelvic inflammatory disease:current concepts in pathogenesis,diagnosis and treatment[J].Infect Dis Clin North Am,2013,27(4):793-809.
[32] WORKOWSKI K A,BERMAN S M.Sexually transmitted diseases treatment guidelines,2006[J].MMWR Recomm Rep,2006,55(RR-11):1-94.
[33] TOSI M F.Innate immune responses to infection[J].J Allergy Clin Immunol,2005,116(2):241-249.
[34] MANTOVANI A.Cancer:Inflaming metastasis[J].Nature,2009,457(7225):36-37.
[35] COUSSENS L M,WERB Z.Inflammation and cancer[J].Nature,2002,420(6917):860-867.
[36] CARVALHO J P,CARVALHO F M.Is Chlamydia-infected tubal fimbria the origin of ovarian cancer?[J].Med Hypotheses,2008,71(5):690-693.
[37] TRABERT B,WATERBOER T,IDAHL A,et al.Antibodies against chlamydia trachomatis and ovarian cancer risk in two independent populations[J].J Nati Cancer Inst,2019,111(2):129-136.
[38] JONSSON S,ODA H,LUNDIN E,et al.Chlamydia trachomatis,Chlamydial heat shock protein 60 and anti-chlamydial antibodies in women with epithelial ovarian tumors[J].Transl Oncol,2018,11(2):546-551.
[39] LABAN M,IBRAHIM E A,HASSANIN A S,et al.Chlamydia trachomatis infection in primary fallopian tube and high-grade serous ovarian cancers:a pilot study[J].Int J Womens Health,2019,11:199-205.
[40] TAYLOR-ROBINSON D,JENSEN J S.Mycoplasma genitalium:from chrysalis to multicolored butterfly[J].Clin Microbiol Rev,2011,24(3):498-514.
[41] CHAN P J,SERAJ I M,KALUGDAN T H,et al.Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA[J].Gynecol Oncol,1996,63(2):258-260.
[42] IDAHL A,LUNDIN E,JURSTRAND M,et al.Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors[J].Infect Dis Obstet Gynecol,2011,2011:824627.
[43] IDAHL A,LUNDIN E,ELGH F,et al.Chlamydia trachomatis,mycoplasma genitalium,neisseria gonorrhoeae,human papillomavirus,and polyomavirus are not detectable in human tissue with epithelial ovarian cancer,borderline tumor,or benign conditions[J].Am J Obstet Gynecol,2010,202(1):71.e1-71.e6.
[44] RÅDESTAD A F,ESTEKIZADEH A,CUI H L,et al.Impact of human cytomegalovirus infection and its immune response on survival of patients with ovarian cancer[J].Transl Oncol,2018,11(6):1292-1300.
[45] DEPTO A S,STENBERG R M.Regulated expression of the human cytomegalovirus pp65 gene:octamer sequence in the promoter is required for activation by viral gene products[J].J Virol,1989,63(3):1232-1238.
[46] CARLSON J W,RÅDESTAD A F,SÖDERBERG-NAUCLE C,et al.Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival[J].Medicine,2018,97(4):e9685.
[47] INGERSLEV K,HØGDALL E,SKOVRIDER-RUMINSKI W,et al.The prevalence of EBV and CMV DNA in epithelial ovarian cancer[J].Infec Agents Cancer,2019,14(1):7. |
